Your browser doesn't support javascript.
loading
Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial.
Friedman-Klabanoff, DeAnna J; Birkhold, Megan; Short, Mara T; Wilson, Timothy R; Meneses, Claudio R; Lacsina, Joshua R; Oliveira, Fabiano; Kamhawi, Shaden; Valenzuela, Jesus G; Hunsberger, Sally; Mateja, Allyson; Stoloff, Gregory; Pleguezuelos, Olga; Memoli, Matthew J; Laurens, Matthew B.
  • Friedman-Klabanoff DJ; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Birkhold M; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Short MT; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Wilson TR; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Meneses CR; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Lacsina JR; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Oliveira F; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Kamhawi S; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Valenzuela JG; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Hunsberger S; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Mateja A; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Stoloff G; PepTcell (t/a SEEK), London, United Kingdom.
  • Pleguezuelos O; ConserV Bioscience, Oxfordshire, United Kingdom.
  • Memoli MJ; Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Laurens MB; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: mlaurens@som.umaryland.edu.
EBioMedicine ; 86: 104375, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36436281
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Arbovirus / Proteínas y Péptidos Salivales / Vacunas de Subunidad / Culicidae Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Animals / Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Arbovirus / Proteínas y Péptidos Salivales / Vacunas de Subunidad / Culicidae Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Animals / Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article